Concepedia

Delila Gasi Tandefelt

DG

8

Publications

1.1K

Citations

8

H-Index

2009

Active since

Affiliations

Institute of Cancer Research(Current)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Royal Marsden NHS Foundation Trust

University of Trento

Istituti di Ricovero e Cura a Carattere Scientifico

Delila Gasi Tandefelt is an author at Institute of Cancer Research specializing in medicine, systems biology, and functional genomics.

ORCID

Top concepts

Publications per year

2009–2020

8

Publications

8

Plasma <i>AR</i> and abiraterone-resistant prostate cancer

Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca et al. · Science Translational Medicine · 2015 · 431 citations · Full text

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

Vincenza Conteduca, Daniel Wetterskog, Mansour T. A. Sharabiani et al. · Annals of Oncology · 2017 · 263 citations · Full text

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration

Jean‐Sébastien Frenel, Suzanne Carreira, Jane Goodall et al. · Clinical Cancer Research · 2015 · 183 citations

Overexpression of Prostate-Specific <i>TMPRSS2(exon 0)-ERG</i> Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer

Karin G. Hermans, Joost L. Boormans, Delila Gasi Tandefelt et al. · Clinical Cancer Research · 2009 · 89 citations · Full text

A 36-gene Signature Predicts Clinical Progression in a Subgroup of ERG-positive Prostate Cancers

Delila Gasi Tandefelt, Joost L. Boormans, Hetty A. van der Korput et al. · European Urology · 2013 · 34 citations

, , +9

Rows per page

1–5 of 8